Press release
HIV Drugs Market Analysis of Key Products and Market Dynamics with a Projected $44.72 Billion by 2031
HIV Drugs Market
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1092
According to the latest research by InsightAce Analytic, the global HIV Drugs market is valued at US$ 31.33 Billion in 2022, and it is expected to reach US$ 44.72 Billion by the year 2031, with a CAGR of 4.70% during a forecast period of 2024-2031.
Acquired immune deficiency syndrome (AIDS), one of the most severe and chronic diseases caused by the human immunodeficiency virus (HIV), is a viral infection transmitted through contact with infected blood, semen, breast milk, and other bodily fluids. The global prevalence of HIV is steadily increasing, with the World Health Organization (WHO) estimating that approximately 33 million people worldwide are currently living with HIV. As awareness of HIV grows, there has been a corresponding rise in testing and diagnosis, which has contributed to an increased demand for highly effective HIV medications to treat and manage the condition.
The growing global prevalence of HIV has significantly driven the demand for HIV drugs, as these medications play a vital role in inhibiting the replication of the virus, thereby reducing the risk of transmission. However, the rescheduling of HIV treatment procedures could lead to a backlog of patients seeking care in the future. In such cases, healthcare providers may recommend medication and lifestyle changes as temporary solutions until treatment can be resumed. In countries like the United States, private hospitals and clinics are also actively involved in the treatment of HIV, though adherence to social distancing measures is still advised. These factors are expected to influence the future trajectory of the HIV drug market.
The primary drivers of market growth for HIV medications include the rising prevalence of HIV and the increasing rate of diagnosis and treatment. Additionally, government initiatives aimed at raising public awareness about HIV, its causes, symptoms, and available treatments are playing a critical role in promoting the importance of these therapies in preventing the spread of the virus. As a result, heightened awareness due to such government efforts is expected to further propel market growth. Despite this, stringent regulatory requirements for the approval and commercialization of HIV drugs are likely to pose challenges to market expansion.
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-02
North America is projected to be the leading contributor to the HIV drugs market over the forecast period, driven by the rising prevalence of HIV infection in the region. According to the Centers for Disease Control and Prevention (CDC), approximately 1.2 million individuals were living with HIV in the United States as of the end of 2018, significantly increasing the demand for HIV medications. Additionally, heightened awareness among the population is further contributing to market growth. Furthermore, the HIV drugs market in the Asia-Pacific region is expected to experience substantial expansion during the forecast period, driven by an aging population and overall population growth.
Major market players operating in the HIV Drugs market include
Gilead Sciences, Janssen, Merck & Co., Bristol-Myers Squibb, TaiMed Biologics, CytoDyn, ViiV Healthcare, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Johnson & Johnson, Cipla Limited, AbbVie, F. Hoffmann-La Roche Ltd., Daiichi Sankyo, Emcure, Hetero Drugs, and Mylan among others.
Recent collaborations and agreements in the market:
• In July 2021, Darunavir paired with ritonavir (DRV/r) will be made available as a second-line medication for HIV patients in low and middle-income countries for US$ 210 per patient/year, according to a pricing agreement announced by Unitaid and the Clinton Health Access Initiative, Inc. (CHAI) and Hetero Labs LTD.
• In March 2021, A partnership contract was struck by Merck and Gilead Sciences Inc. to develop and market long-acting HIV treatment jointly. The firms want to combine Merck's investigational nucleoside reverse transcriptase translocation inhibitor islatravir and Gilead's investigational capsid inhibitor lenacapavir to produce a two-drug regimen for HIV.
• In January 2021, ViiV Healthcare created Cabenuva, an injectable drug authorized by the US Food and Drug Administration to treat adult patients with human immunodeficiency virus type 1 (HIV) infections.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1092
Market Segments
Global HIV Drugs Market, by Product, 2022-2030 (Value US$ Bn)
• Zolgensma
• Atripla
• Biktarvy
• Complera
• Delstrigo
• Descovy
• Dovato
• Genvoya
• Isentress
• Juluca
• Odefsey
• Stribild
• Symtuza
• Tivicay
• Triumeq
• Trogarzo
• Truvada
• Cabotegravir/Rilpivirine
• Fostemsavir
• Leronlimab
• Others
Global HIV Drugs Market, by Region, 2022-2030 (Value US$ Bn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America HIV Drugs Market, by Country, 2022-2030 (Value US$ Bn)
• U.S.
• Canada
Europe HIV Drugs Market, by Country, 2022-2030 (Value US$ Bn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific HIV Drugs Market, by Country, 2022-2030 (Value US$ Bn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America HIV Drugs Market, by Country, 2022-2030 (Value US$ Bn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa HIV Drugs Market, by Country, 2022-2030 (Value US$ Bn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa
Why should buy this report:
To receive a comprehensive analysis of the prospects for the global HIV Drugs market
To receive an industry overview and future trends of the HIV Drugs market
To analyze the HIV Drugs market drivers and challenges
To get information on the HIV Drugs market value (US$Bn) forecast to 2030
Significant investments, mergers & acquisitions in the HIV Drugs market industry
Read Overview Report- https://www.insightaceanalytic.com/report/global-hiv-drugs-market-/1092
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release HIV Drugs Market Analysis of Key Products and Market Dynamics with a Projected $44.72 Billion by 2031 here
News-ID: 3985034 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
4PL Logistics Market Revenue Report with Forecast to 2034
"4PL Logistics Market" in terms of revenue was estimated to be worth $59.6 Billion in 2024 and is poised to reach $133.3 Billion by 2034, growing at a CAGR of 8.5% from 2025 to 2034 according to a new report by InsightAce Analytic.
Get Free Sample Report @
https://www.insightaceanalytic.com/request-sample/1609
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global 4PL Logistics Market are:
• Rapid growth of automotive the…
Heavy-Duty Autonomous Vehicle Market Exclusive Trends Analysis with Forecast to …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Heavy-Duty Autonomous Vehicle Market- (By Application (Logistics, Public Transportation, Construction and Mining, Others), By Propulsion Type (Internal Combustion Engine Vehicles, Electric Vehicles), By Vehicle Type (Heavy Trucks, Heavy Buses, Roboshuttles), By Level of Autonomy (Fully Autonomous Vehicles, Semi-Autonomous Vehicles), By Sensor Type (LiDAR, RADAR, Camera, Others)) Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According…
E-Commerce Logistics Market Exclusive Report with Detailed Study Analysis
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global E-Commerce Logistics Market Size, Share & Trends Analysis Report By Service Type (Transportation And Warehousing) And Operational Area (International And Domestic)- Market Outlook And Industry Analysis 2034"
The global e-commerce logistics market is estimated to reach over USD 5340.2 billion by 2034, exhibiting a CAGR of 26.4% during the forecast period.
Request For Free Sample Pages:…
E-bikes Market Exclusive Report on the Latest Revenue and Future Scope
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global E-bikes Market Size, Share & Trends Analysis Report By Class (Class-I, Class-II, Class-III), Speed (Up to 25km/h, 25-45 km/h), Battery Type (Lithium-ion, Lithium-ion Polymer, Lead Acid), Mode (Pedal Assist, Throttle), Component (batteries, electric motors, frames with forks, wheels, crank gears, brake systems and motor controllers) , Motor Type (hub and mid), Usage (mountain, trekking, city/urban,…
More Releases for HIV
HIV Drugs Market - Defeating HIV Together: Advancing Treatment Options for a Bri …
Newark, New Castle, USA: The "HIV Drugs Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
HIV Drugs Market: https://www.growthplusreports.com/report/hiv-drugs-market/7792
This latest report researches the industry structure, sales, revenue,…
HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is …
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence of…
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication…
HIV Therapeutics Market– South Africa's Aspen launches three-in-one HIV drug
Recent Developments
Aspen Pharma care, a South Africa’s drug maker has launched a triple combination of tablet for the treatment of HIV in the country where the HIV virus is the most prevalent. The company's new Emdolten drug is a once a day tablet which is in the form of dolutegravir, an antiretroviral medication that balances the drug’s resistance. The company has launched Aspen Stavudine which was its first generic ARV…
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Introduction to Human Immunodeficiency Virus (HIV) Vaccines
1.1 Overview
1.2 Antiquity of HIV Vaccine
Need for the Development of HIV Vaccine
Primer of HIV inside the Body
3.1 Inclusion of HIV Virus into the System
3.2 Interaction of HIV with Host
3.3 Eradication of HIV Virus
HIV Vaccine Development Process
4.1 Introduction
…
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways…
